Allspring Global Investments Holdings, LLC Jounce Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$0.64 - $1.99 $10 - $33
-17 Reduced 2.21%
753 $0
Q2 2022

Jul 25, 2022
SELL
$2.8 - $7.67 $202,070 - $553,528
-72,168 Reduced 98.94%
770 $2,000
Q1 2022

May 02, 2022
SELL
$6.01 - $8.54 $34,593 - $49,156
-5,756 Reduced 7.31%
72,938 $495,000
Q4 2021

Jan 28, 2022
BUY
$7.11 - $9.64 $559,514 - $758,610
78,694 New
78,694 $657,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email